Veery Capital LLC Sells 442 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Veery Capital LLC cut its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 53.3% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 387 shares of the healthcare conglomerate’s stock after selling 442 shares during the quarter. Veery Capital LLC’s holdings in UnitedHealth Group were worth $203,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors also recently added to or reduced their stakes in the company. NewSquare Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in UnitedHealth Group during the fourth quarter valued at approximately $26,000. Hurley Capital LLC bought a new stake in UnitedHealth Group during the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd bought a new stake in UnitedHealth Group during the fourth quarter valued at approximately $30,000. Finally, Promus Capital LLC bought a new position in shares of UnitedHealth Group in the fourth quarter worth approximately $32,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

NYSE UNH opened at $301.08 on Friday. The stock has a market capitalization of $273.12 billion, a PE ratio of 19.42, a P/E/G ratio of 1.37 and a beta of 0.56. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The business has a 50 day simple moving average of $430.87 and a two-hundred day simple moving average of $494.23. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same quarter last year, the firm posted $6.91 EPS. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms have weighed in on UNH. Argus lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, April 21st. KeyCorp dropped their price target on shares of UnitedHealth Group from $575.00 to $450.00 and set an “overweight” rating for the company in a research report on Wednesday, May 14th. Robert W. Baird dropped their price target on shares of UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating for the company in a research report on Wednesday, May 14th. Bank of America lowered shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and dropped their price target for the stock from $560.00 to $350.00 in a research report on Wednesday, May 14th. Finally, Barclays dropped their target price on shares of UnitedHealth Group from $513.00 to $362.00 and set an “overweight” rating for the company in a research report on Thursday, May 15th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $441.87.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Kristen Gil acquired 3,700 shares of the company’s stock in a transaction that occurred on Thursday, May 15th. The stock was bought at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the acquisition, the director now directly owns 3,818 shares in the company, valued at $1,035,327.06. The trade was a 3,135.59% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the company’s stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the acquisition, the chief executive officer now owns 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 109,408 shares of company stock worth $31,607,768. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.